RNA-seq of AML cells with MPI KO and FLT3 tyrosine kinase inhibition
Molm13 AML cell line both control and MPI KO, treated with AC220 (quizartinib) and mannose at 24 and 72 hours after drug treatment. 2 reads and 2 repeats for each condition, 2 timepoints, 48 total files.